You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 5,196,205


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,196,205
Title: Method for treatment of gastro intestinal disorders
Abstract:A method is disclosed for preventing recurrence of duodenal ulcer associated with Campylobacter pylori infection in a patient suffering from duodenal ulcer disease associated with Campylobacter pylori infection by administering a pharmaceutically acceptable bismuth compound; a first antibiotic selected from the group consisting of tetracycline and penicillins and second antibiotic which is metronidazole.
Inventor(s): Borody; Thomas J. (Five Dock, AU)
Assignee:
Application Number:07/466,310
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,196,205

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,196,205

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPI4838Oct 12, 1987
AustraliaPI5985Dec 18, 1987
AustraliaPI7513Mar 30, 1988
PCT Information
PCT FiledSeptember 29, 1988PCT Application Number:PCT/AU88/00379
PCT Publication Date:October 23, 1986PCT Publication Number: WO86/05981

International Family Members for US Patent 5,196,205

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 100324 ⤷  Sign Up
Australia 2540588 ⤷  Sign Up
Australia 623868 ⤷  Sign Up
Canada 1330759 ⤷  Sign Up
Germany 3887353 ⤷  Sign Up
European Patent Office 0439453 ⤷  Sign Up
Japan 2733849 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.